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Abstract
The reliability of self-reported treatment data is unclear. Therefore 350 (58% response) breast cancer patients
completed a questionnaire to compare self-reported data with data from medical records. Agreement was
good for type of surgery, receiving chemotherapy, endocrine and radiation therapy. Only moderate agreement
was seen for sentinel node biopsy, pathological results an axillary lymph node dissection.
Objectives:Medical records are considered the gold standard for accurate treatment information. However, treatment
data are increasingly obtained from questionnaires. It can be questioned whether self-reported treatment data are
reliable, particularly because patients have to process a lot of information during their diagnosis and treatment pro-
cess. The present study assesses the reliability of self-reported treatment data compared with medical records.
Methods: All patients with stage I, II, and III breast cancer (n ¼ 606) in 5 hospitals in the west of the Netherlands were
invited to complete a questionnaire 9 to 18 months after surgery. We calculated kappa statistics, proportion correct,
sensitivity, specificity, and positive and negative predictive values to assess agreement. Results: Three hundred fifty
patients completed the questionnaire (58%). Agreement was good for type of surgery and receiving chemotherapy,
endocrine therapy, and radiation therapy, with sensitivity and specificity of 95% or higher and kappa above 0.90.
However, only moderate agreement was seen for sentinel node biopsy, including the pathologic results and axillary
lymph node dissection (kappa between 0.60 and 0.80). Lack of agreement was more often found for patients who had
received endocrine therapy (odds ratio, 1.85; 95% confidence interval, 1.11-3.10) but not influenced by age (odds
ratio, 1.00; 95% confidence interval, 0.98-1.02). Conclusion: Accuracy of self-reported data is high for type of surgery,
chemotherapy, endocrine therapy, and radiation therapy, but much lower for sentinel node biopsy including the
pathologic results and axillary lymph node dissection. This is relevant for clinicians given the time spent explaining
these procedures, and for researchers to help decide what information to obtain from patients or medical records.
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Clinical Breast Cancer June 2018Outcome Measures as part of routine clinical practice as well as for
research, self-reported treatment data could be a feasible alternative
if the self-reported information is sufficiently reliable. Previous
studies suggest that self-reported treatment data are accurate for
broad categories of treatment such as chemotherapy and surgery.1-5
However, since these studies were conducted, some things have
changed in clinical practice that may influence the results. Treatment
decisions at present are more frequently made by doctor and patient
together.6 As a result, patients receive more and more information
about their disease, especially in oncology.7-9 Various studies among
patients with (breast) cancer showed that patients want to be fully
informed and share decision-making responsibility.6-9 This may result
in better recall of this information by patients, because of their1526-8209/ª 2017 The Authors. Published by Elsevier Inc. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
http://dx.doi.org/10.1016/j.clbc.2017.08.005
involvement in the decision-making. On the other hand, there is an
increased number of choices to make during the treatment period,
and therefore, patients with breast cancer receive even more infor-
mation to process than they did in the past,5 which may limit the
accurateness by which patients recall their treatment data. In addi-
tion, past studies did not assess the accurateness of self-reported
sentinel node biopsy data, in part because these were not available
at the time. Only 1 previous study assessed the accurateness of self-
reported data about axillary lymph node dissections being per-
formed,2 describing a high proportion of agreement on this treatment
regimen (97%; kappa 0.89).
Therefore, the present study aims to assess the agreement
between self-reported data collected using a questionnaire, and
clinical data of these patients collected using the hospital informa-
tion systems on different breast cancer treatments including the
sentinel node biopsy being performed, the pathologic result, and
having received an axillary lymph node dissection.
Methods
The Importance for Mamma patients of PAtient reported out-
comes in Choice of Therapy (IMPACT) study is an internet-based
questionnaire study, investigating which outcomes of treatment for
breast cancer are most important to patients in their judgement for
good quality of care by using conjoint analysis. Details of the design
and data collection have been described previously.10 Within this
study, patients reported data about the treatment they received; we
also collected this treatment data from the medical records.
Ethics
The study was approved by the Medical Ethics Committee of the
Leiden University Medical Center (project number P13.211).
Patients
All patients (n ¼ 606) with stage I, II, and III breast cancer were
selected in 5 hospitals in the western part of the Netherlands and
invited to participate. Patients were selected if they were at least 18
years of age, and underwent surgery for breast cancer 9 to 18
months ago. The invitations and informed consent forms were sent
by mail. Reminders were sent after 3 weeks.
Questionnaire
The first part of the questionnaire consisted of questions about
the respondent and her diagnosis with and treatment for breast
cancer. Questions about the received treatment included: (1) Type
of surgery: breast conserving therapy versus mastectomy; (2)
Sentinel node biopsy: performed versus not performed; (3) Patients
who underwent a sentinel node procedure also answered a question
about the pathologic results from this procedure: tumor-positive or
tumor-negative; (4) Axillary lymph node dissection: performed
versus not performed; (5) Chemotherapy: received versus not
received; (6) Endocrine therapy: received versus not received; and
(7) Radiation therapy: received versus not received.
Clinical Data
Clinical data of all invited patients were collected from the
medical records. The collected data included: type of surgery
(breast-conserving therapy or mastectomy), sentinel node procedure(performed or not performed), axillary lymph node dissection
(performed or not performed), chemotherapy (received or not
received), endocrine therapy (received or not received), radiation
therapy (received or not received), and pathologic result from
sentinel node procedure (tumor-positive or tumor-negative).
Statistical Analysis
Baseline characteristics were compared between respondents and
nonrespondents, using c2 and t tests. This was done to assess
whether the respondents were representative for the total population
of patients with breast cancer. In case of expected counts less than 5,
the Fisher exact test was used.
Agreement between self-reported treatment data and medical
records was first assessed by calculating the kappa statistic. Next,
agreement was analyzed by calculating the proportion of correct
answers and sensitivity and specificity, as well as the positive and
negative predictive values. In all these analyses, the medical records
data were considered as the gold standard.
Multiple logistic regression analysis were conducted to examine
whether lack of agreement between self-reported treatment and the
medical records was influenced by age, receiving chemotherapy, and
receiving endocrine therapy because these treatment regimens are
known to influence the cognition of patients.11 Receiving chemo-
therapy or endocrine therapy as noted in the medical records were
included as independent variables besides age. This was done for the
different types of treatment separately as well as overall, using lack of
agreement on (at least 1) treatment (yes/no) as the dependent variable.
All data were analyzed using the statistical package SPSS for
Windows 17.0 (SPSS Inc, Chicago, IL). Descriptive data are given
as a mean (SD) or median (range). In all analyses, P < .05 was
considered statistically significant.
Results
In total, 350 patients returned a complete questionnaire
(response rate, 58%).
Respondents are, on average, 7 years younger than non-
respondents (Table 1). Among the respondents, there were more
patients who received chemotherapy (50% vs. 31%) and radiation
therapy (72% vs. 60%) than among the nonrespondents.
Overall, 2334 questions were answered by these 350 patients, and
138 questions were answered incorrectly compared with the medical
records (5.9%). In total, 108 patients answered 1 or more questions
incorrectly (31%), 83 patients answered 1 question incorrectly, 21
patients answered 2 questions incorrectly, 3 patients answered 3
questions incorrectly, and 1 patient answered 4 questions incorrectly.
Agreement by type of treatment is summarized in Table 2. The
proportion of patients who correctly reported type of surgery, having
chemotherapy, endocrine therapy, and radiation therapy was 95% or
higher. Sensitivity and specificity along with positive and negative
predictive values were also above 95%, and the kappa statistic was
above 0.90 for each of these treatments, indicating good agreement.
However, agreement was lower for sentinel node biopsy including the
pathologic result and axillary lymph node dissection. The proportion
of patients who correctly reported a sentinel node biopsy being per-
formed, the pathologic results of the sentinel node biopsy, and un-
dergoing axillary lymph node dissection were all below 90%, with the
kappa statistic showingmoderate agreement (between 0.60 and 0.80).Clinical Breast Cancer June 2018 - 235
Table 1 Differences in Baseline Characteristics Between Respondents and Nonrespondents




Mean age, y (SD) 59.3 (11.6) 66.3 (13.8) t ¼ 6.49
Range 27-93 31-95 P <.01
Tumor
Invasive ductal carcinoma 230 (66) 149 (59)
Invasive lobular carcinoma 61 (18) 44 (17)
Ductal carcinoma in situ 40 (11) 34 (13)
Other (pre)malignant 16 (5) 24 (10) c2 ¼ 7.96
Benign 1 (0) 2 (1) P ¼ .14
Type of surgery
Mastectomy 142 (41) 116 (45) c2 ¼ 1.36
Breast-conserving therapy 208 (59) 140 (55) P ¼ .24
Axillary lymph node dissection
Yes 88 (25) 73 (29) c2 ¼ 0.88
No 261 (75) 182 (71) P ¼ .35
Chemotherapy
Yes 169 (50) 76 (31) c2 ¼ 21.15
No 172 (50) 172 (69) P <.01
Endocrine therapy
Yes 170 (50) 130 (52) c2 ¼ 0.30
No 169 (50) 118 (48) P ¼ .59
Radiation therapy
Yes 252 (72) 151 (60) c2 ¼ 10.39
No 97 (28) 102 (40) P <.01
Intraoperative radiation therapy
Yes 69 (20) 39 (15) c2 ¼ 5.75
No 281 (80) 215 (85) P ¼ .10
Significant differences are indicated in bold.
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self-reported data and the medical records, when adjusted for the
effects of receiving chemotherapy and endocrine therapy (Table 3).Table 2 Agreement Between Self-reported Treatment and Medical
Proportion
Correct,a % Sensitivity, % Specificit
Surgery
Lumpectomy 97.6 97.6 99.3
Mastectomy 99.3 99.3 97.6
Sentinel node 89.1 95.9 66.7
Pathologic result
sentinel node
Positive 85.9 85.9 94.6
Negative 94.2 94.6 85.9
ALND proceeded 86.8 93.2 84.7
Chemotherapy 97.7 98.2 97.1
Endocrine therapy 96.2 95.9 96.4
Radiation therapy 97.7 98.8 94.8
Abbreviations: ALND ¼ axillary lymph node dissection; NPV ¼ negative predictive value; PPV ¼ po
aUsing medical records as the gold standard.
Clinical Breast Cancer June 2018The same is true for receiving chemotherapy. However, among
patients who received endocrine therapy, more often lack of
agreement was found for any treatment (odds ratio, 1.95; 95%Records











Table 3 Influence of Age, Receiving Chemotherapy, and Receiving Endocrine Therapy on Lack of Agreement Between Self-reported
Treatment and Medical Records
Age Chemotherapy Endocrine Therapy
OR 95% CI OR 95% CI OR 95% CI
Any treatment 1.00 0.98-1.02 1.32 0.73-2.38 1.85 1.11-3.10
Type of surgery 1.02 0.94-1.10 0.75 0.10-5.93 0.56 0.09-3.52
SN performed 1.00 0.97-1.04 1.66 0.69-3.99 1.05 0.49-2.24
Pathology SN 0.97 0.92-1.02 3.32 0.78-14.09 1.85 0.60-5.68
ALND 0.98 0.95-1.02 0.64 0.28-1.46 2.75 1.31-5.79
Chemotherapy 0.97 0.91-1.04 0.29 0.05-1.76 2.57 0.53-12.52
Endocrine therapy 1.05 0.99-1.11 1.42 0.34-5.84 1.13 0.34-3.70
Radiation therapy 1.01 0.93-1.08 0.89 0.14-1.08 0.78 0.15-4.07
Significant differences are indicated in bold.
Abbreviations: ALND ¼ axillary lymph node dissection; CI ¼ confidence interval; OR ¼ odds ratio; SN ¼ sentinel node.
Melissa Kool et alconfidence interval, 1.11-3.10). This seems to be owing to the lack
of agreement on reporting axillary lymph node dissection, which
was observed more often in the group of patients who received
endocrine therapy (odds ratio, 2.75; 95% confidence interval, 1.31-
5.79) (Table 3). For all other treatment regimens, there were no
differences in lack of agreement by age, receiving chemotherapy,
and receiving endocrine therapy.
Discussion
The present study has shown that most women correctly answered
type of surgery received, as well as chemotherapy and endocrine and
radiation therapy, with sensitivity and specificity of 95%or higher and
kappa above 0.90. However, sentinel node biopsy, including the
positive or negative pathologic result, and an axillary lymph node
dissection being performed were reported with only moderate
agreement (kappa between 0.60 and 0.80). A lack of agreement was
more often found for patients who had received endocrine therapy,
specifically regarding axillary lymph node dissection, but not influ-
enced by age. Overall, about one-third (31%) of patients answered 1
or more questions regarding treatment incorrectly.
These results confirm that the accuracy of self-reporteddata compared
with medical records was high for most broad categories of treatment
received, as found in previous studies.1-5However, the accuracy reported
for axillary lymph node dissection in the current study was much lower
than in a previous study.7 Agreement regarding sentinel node biopsy and
pathologic results of the biopsy was not investigated before, given that
these became part of routine practice in recent years, but also showed
moderate agreement. Age did not influence the lack of agreement be-
tween self-reporteddata and themedical records, but receiving endocrine
therapy did, particularly regarding axillary lymph node dissection. This
could be explained by the previously proven effect of endocrine therapy
on cognition and memory.12-14 The question is whether information
about these treatment regimens is not remembered well by patients, or
not understood, or not explained correctly by doctors. This should be
investigated in future studies to get clues on how this can be improved so
that these can be reliably assessed using self-reported data.
Study Limitations
Our sample may have been a selected population, as it was shown
that respondents were younger than nonrespondents. Therefore,
response bias may have occurred, but this will only affect the resultsif the lack of agreement was also influenced by age. Age did not
influence the lack of agreement; thus, our younger sample is likely to
give results representative for the total population. Similarly, more
responding patients received radiation therapy and chemotherapy,
but there was no difference in the lack of agreement between pa-
tients who did or did not receive radiation therapy or chemotherapy,
so this will not have affected the results. Finally, a limitation of the
study is that we did not have data available on patient characteristics
like education, income, and literacy or on stage of cancer, so that the
influence of these variables on agreement could not be assessed.Conclusion
In conclusion, the current study confirms previous studies
concluding that the accuracy of self-reported data is high for most
broad categories of treatment. The present study adds that the
accuracy of self-reported data about sentinel node biopsy, pathologic
results of the biopsy, and axillary lymph node dissection is much
lower and shows only moderate agreement. This is relevant for
clinicians, given the time spent explaining these procedures, and for
researchers to help them decide what information to obtain from
patients or medical records. Future studies should investigate the
causes for such lack of agreement, and whether this is owing to
information not being understood by patients, not being well-
explained by doctors, or the large amount of information that
needs to be processed. This is likely to improve both the informa-
tion provision to patients and to contribute to patients being able to
participate in shared decision-making.Clinical Practice Points
 Medical records are still considered the golden standard to obtain
reliable information on breast cancer treatment data.
 However, this is time consuming and self-reported treatment
data could be a feasible alternative if the self-reported informa-
tion is sufficiently reliable.
 Previous studies suggest that self-reported treatment data are
accurate for broad categories of treatment such as chemotherapy
and surgery.
 Past studies did not assess the accurateness of self-reported
sentinel node biopsy data, in part because these were not avail-
able at the time.Clinical Breast Cancer June 2018 - 237
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ported data about axillary lymph node dissections being
performed.
 The current results confirms previous studies concluding accu-
racy of self-reported data is high for most broad categories of
treatment.
 The present study adds that accuracy of self-reported data about
sentinel node biopsy, pathological results of the biopsy and
axillary lymph node dissection is much lower and shows only
moderate agreement.
 This is relevant for clinicians given the time spent explaining
these procedures, and for researchers to help them decide which
information to obtain from patients or medical records.
 Future studies should investigate the causes for such lack of
agreement, and whether this is due to information not being
understood by patients, not well explained by doctors or due to
the large amount of information that needs to be processed.
 This is likely to improve both the information provision to pa-
tients and likely to contribute to patients being able to participate
in shared decision making.Acknowledgment
The authors would like to thank E.M.M. Krol-Warmerdam and
G.M.C. Ranke for their help in developing the questionnaires; A.
Does-den Heijer, M. Goemans, H. de Lange-van Bruggen, M.E.M.
Bouwman, K.M. Fennema-Bensink, A.H. van der Wilden, and
P.H.B. Keunen-Dekkers for their help in collecting data; and M.L.
Smidt for her advice and expert opinion.
The study is funded by Zoleon, a regional charity organization
that aims to improve quality of care and welfare for oncologic
patients, project number 13.06.Clinical Breast Cancer June 2018Disclosure
The authors have stated that they have no conflicts of interest.References
1. Barisic A, Glendon G, Weerasooriya N, Andrulis IL, Knight JA. Accuracy of self-
reported breast cancer information among women from the Ontario site of the
breast cancer family registry. J Cancer Epidemiol 2012; 2012:310804.
2. Maunsell E, Drolet M, Ouhoummane N, Robert J. Breast cancer survivors accurately
reported key treatment and prognostic characteristics. J Clin Epidemiol 2005; 58:364-9.
3. Phillips KA, Milne RL, Buys S, et al. Agreement between self-reported breast
cancer treatment and medical records in a population-based breast cancer family
registry. J Clin Oncol 2005; 23:4679-86.
4. Gupta V, Gu K, Chen Z, Lu W, Shu XO, Zheng Y. Concordance of self-reported
and medical chart information on cancer diagnosis and treatment. BMC Med Res
Methodol 2011; 11:72.
5. Liu Y, Diamant AL, Thind A, Maly RC. Validity of self-reports of breast cancer
treatment in low-income, medically underserved women with breast cancer. Breast
Cancer Res Treat 2010; 119:745-51.
6. Stiggelbout AM, Van der Weijden T, De Wit MPT, et al. Shared decision making:
really putting patients at the centre of healthcare. BMJ 2012; 344:e256.
7. Barnato AE, Llewellyn-Thomas HA, Peters EM, Siminoff L, Collins ED, Barry MJ.
Communication and decision making in cancer care: setting research priorities for
decision support/patients’ decision aids. Med Decis Making 2007; 27:626-34.
8. Cox A, Jenkins V, Catt S, Langridge C, Fallowfield L. Information needs
and experiences: an audit of UK cancer patients. Eur J Oncol Nurs 2006; 10:
263-72.
9. Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results
from a large study in UK cancer centres. Br J Cancer 2001; 84:48-51.
10. Kool M, van der Sijp JR, Kroep JR, et al. Importance of patient reported outcome
measures versus clinical outcomes for breast cancer patients evaluation on quality
of care. Breast 2016; 27:62-8.
11. Menning S, de Ruiter MB, Kieffer JM, et al. Cognitive impairment in a subset of
breast cancer patients following systemic therapy e results from a longitudinal
study. J Pain Symptom Manage 2016; 52:560-9.e1.
12. Bedard M, Verma S, Collins B, Song X, Paquet L. Prospective memory impair-
ment in chemotherapy-exposed early breast cancer survivors: preliminary evidence
from a clinical test. J Psychosoc Oncol 2016; 34:291-304.
13. Prokasheva S, Faran Y, Cwikel J, Geffen DB. Analysis of memory deficits following
chemotherapy in breast cancer survivors: evidence from the doors and people test.
J Psychosoc Oncol 2011; 29:499-514.
14. Lyon DE, Cohen R, Chen H, et al. The relationship of cognitive performance to
concurrent symptoms, cancer- and cancer-treatment-related variables in women
with early-stage breast cancer: a 2 year longitudinal study. J Cancer Res Clin Oncol
2016; 142:1461-74.
